Karen L Fink

Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.

Caterina Giannini, Walter J Curran, Jan C Buckner, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

Timothy F Cloughesy, Mark R Gilbert, Patrick Y Wen, 2008, Neuro-oncology.